MAGELLAN LONGEVITY
HomeResearchStudy library › Olive leaf extract effect on cardiometabolic profile among adults…
Study summary · Cardiovascular & vascular aging

What is the effectiveness of olive leaf extract on cardiometabolic profiles among adults with prehypertension and hypertension?

In one paragraph

Olive Leaf Extract, a systematic review and meta-analysis in 325 patients (PeerJ 2021, PMID 33868820) — a daily dose of 500 mg of olive leaf extract significantly reduced systolic BP by -5.78 mmHg over at least 8 weeks compared to placebo, but had no significant effect on diastolic BP. The main limitation is the small number of participants across the included trials, which may affect the robustness of the conclusions.

Source: PeerJ 2021, PMID 33868820 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

PeerJ · 2021 · PMID 33868820 · DOI 10.7717/peerj.11173

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Olive leaf extract may help reduce systolic blood pressure, LDL, and inflammatory markers, but more research is needed to confirm its overall cardiometabolic benefits.

The question

What is the effectiveness of olive leaf extract on cardiometabolic profiles among adults with prehypertension and hypertension?

What they tested

The study hypothesized that olive leaf extract would improve cardiometabolic profiles in prehypertensive and hypertensive individuals.

How they did it

This systematic review and meta-analysis included five randomized clinical trials with 325 patients aged 18-80 years. Data from Cochrane, Medline, Embase, and trial registries were analyzed using random effects models to estimate mean differences and 95% confidence intervals for continuous outcomes. Primary outcomes were changes in systolic and diastolic blood pressure, while secondary outcomes included lipid profile, glucose metabolism, inflammatory markers, and kidney/liver functions.

What they found

A daily dose of 500 mg of olive leaf extract significantly reduced systolic BP by -5.78 mmHg over at least 8 weeks compared to placebo, but had no significant effect on diastolic BP. A 1,000 mg daily dose of olive leaf extract versus captopril reduced LDL by -6.00 mg/dl. The 500 mg daily dose also reduced inflammatory markers IL-6 by -6.83 ng/L, IL-8 by -8.24 ng/L, and TNF-alpha by -7.40 ng/L compared to placebo. No significant changes in systolic or diastolic BP were found for 1,000 mg/day of a combined formulation or 1,000 mg/day of olive leaf extract alone versus placebo.

Impact of Olive Leaf Extract on Key Cardiometabolic Markers
Values shown: Mean Difference
Systolic BP (500mg OLE vs Placebo)-5.78
LDL (1000mg OLE vs Captopril)-6
IL-6 (500mg OLE vs Placebo)-6.83
IL-8 (500mg OLE vs Placebo)-8.24
TNF-alpha (500mg OLE vs Placebo)-7.4

Mean differences in mmHg for systolic BP and mg/dl or ng/L for other markers, showing reductions with olive leaf extract.

What it means

Olive leaf extract may reduce systolic blood pressure, LDL cholesterol, and inflammatory biomarkers. However, the limited number of participants in the included trials prevents a robust conclusion regarding its overall effects on cardiometabolic profiles.

Limitations

The main limitation is the small number of participants across the included trials, which may affect the robustness of the conclusions.

“500 mg olive leaf extract showed a significant reduction in systolic BP”— from the published abstract, PeerJ 2021

The paper at a glance

TitleOlive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a meta-analysis
JournalPeerJ
Year2021
PMID33868820 ↗
DOI10.7717/peerj.11173 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Olive Leaf Extract (Oleuropein)

In human trials, standardized olive leaf extract has most consistently produced modest reductions in systolic and diastolic blood pressure in people with prehypertension or hypertension, and several trials and meta-analyses also report small decreases in total and LDL cholesterol and triglycerides.

Olive Leaf Extract (Oleuropein)

Olive leaf extract (OLE) is a botanical preparation derived from the leaves of the olive tree (Olea…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the effectiveness of olive leaf extract on cardiometabolic profiles among adults with prehypertension and hypertension? [Plain-English summary of PeerJ 2021, PMID 33868820, DOI 10.7717/peerj.11173]. Magellan Longevity. https://magellanlongevity.com/study/d33868820.html
BibTeX
@misc{magellan_d33868820, title = {What is the effectiveness of olive leaf extract on cardiometabolic profiles among adults with prehypertension and hypertension?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d33868820.html}}, note = {Plain-English summary of PubMed PMID 33868820; DOI 10.7717/peerj.11173; PeerJ 2021. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d33868820.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 33868820 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.